Cholinergic neurons are endowed with a high-affinity choline uptake system for efficient synthesis of acetylcholine at the presynaptic terminals. The high-affinity choline transporter CHT1 is responsible for choline uptake, the rate-limiting step in acetylcholine synthesis. However, endogenous physiological factors that affect CHT1 expression or function and consequently regulate the acetylcholine synthesis rate are essentially unknown. Here we demonstrate that extracellular substrate decreases the cell-surface expression of CHT1 in rat brain synaptosomes, primary cultures from the basal forebrain, and mammalian cell lines transfected with CHT1. Extracellular choline rapidly decreases cell-surface CHT1 expression by accelerating its internalization, a process that is mediated by a dynamin-dependent endocytosis pathway in HEK293 cells. Specific inhibitor hemicholinium-3 decreases the constitutive internalization rate and thereby increases cell-surface CHT1 expression. We also demonstrate that the constitutive internalization of CHT1 depends on extracellular pH in cultured cells. Our results collectively suggest that the internalization of CHT1 is induced by extracellular substrate, providing a novel feedback mechanism for the regulation of acetylcholine synthesis at the cholinergic presynaptic terminals.
Introduction
In cholinergic neurons, acetylcholine synthesis relies on highaffinity choline uptake to ensure an efficient choline supply from extracellular fluid at the presynaptic terminals (Kuhar and Murrin, 1978; Tucek, 1985; Okuda and Haga, 2003) . Choline uptake is the rate-limiting and regulatory step in acetylcholine synthesis and sustained release. CHT1 is the high-affinity choline transporter that is responsible for this Na ϩ -dependent, high-affinity choline uptake that is sensitive to hemicholinium-3 (HC-3) , and it is specifically expressed in cholinergic neurons Misawa et al., 2001; Kobayashi et al., 2002; Lips et al., 2002; Kus et al., 2003) . The fact that HC-3 administration to animals causes lethal respiratory failure (Schueler, 1955) and that CHT1 knock-out mice die shortly after birth as a result of hypoxia from a respiratory failure underscore the physiological significance of CHT1 function in cholinergic neurotransmission.
Regulation of high-affinity choline uptake is therefore critical for cholinergic function, but the molecular mechanisms that regulate CHT1 expression and function are not fully elucidated. It has been revealed recently that CHT1 expression is regulated by several factors at the transcriptional level (Brandon et al., 2004; Brock et al., 2007; Madziar et al., 2008; Krishnaswamy and Cooper, 2009) . At the posttranslational level, cellular trafficking has emerged as an important regulatory mechanism of CHT1. Although it is essential for CHT1 to function at the plasma membrane, most CHT1 proteins are localized intracellularly at synaptic vesicles Ribeiro et al., 2003; Nakata et al., 2004) . Studies using cultured cell lines showed that CHT1 is continuously internalized from the plasma membrane via the clathrin-mediated endocytosis pathway in which a dileucine-like motif located in the C-terminal cytoplasmic region of CHT1 is involved (Ribeiro et al., 2003 (Ribeiro et al., , 2005 . It has long been known that high-affinity choline uptake is acutely regulated by neuronal activity in the cholinergic nerve terminals (Simon and Kuhar, 1975) . Depolarization induces an increase in the maximal uptake rate of choline (Murrin and Kuhar, 1976) or in the maximal binding capacity of HC-3 (Saltarelli et al., 1987) , suggesting the increase in cell-surface expression of CHT1. This has recently been explained by activity-dependent vesicular trafficking of the intracellular pool of CHT1 to the plasma membrane Ribeiro et al., 2003 Ribeiro et al., , 2007 Ivy et al., 2010) . Cellular trafficking of CHT1 may also be regulated by its phosphorylation (Gates et al., 2004) or its interaction with other proteins, such as the amyloid-␤ precursor protein (Wang et al., 2007) . However, the endogenous physiological factors regulating the expression level of CHT1 at the plasma membrane remain to be elucidated.
Here, we report that extracellular choline decreases the cellsurface expression of the high-affinity choline transporter CHT1 in rat brain synaptosomes and cultured cells, whereas the specific inhibitor HC-3 increases it. These regulations result from the alterations of the rate of CHT1 internalization.
Materials and Methods

Materials.
A plasmid (pcDNA3.1) encoding human CHT1 (hCHT1) has been described previously . For constructing hCHT1 tagged with the FLAG epitope at the N terminus (FLAG-hCHT1), the hCHT1 coding sequence was cloned into EcoRI and BamHI sites of pFLAG-CMV-4 (Sigma). Plasmids encoding GFP-tagged dynamin 2 or the dominant-negative mutant (K44A) were kind gifts from Dr. Mark McNiven (Mayo Clinic, Rochester, MN). Stable hCHT1-expressing HEK293 cell lines were established by transfection with a plasmid pcDNA3.1-hCHT1 or pFLAG-CMV-hCHT1 and selection by culturing in medium containing 500 g/ml G418 (Invitrogen) for 4 weeks. Rabbit anti-CHT1 polyclonal antibody has been described previously . Rabbit polyclonal antibody against AP-2 2 was a gift from Dr. Juan S. Bonifacino (National Institutes of Health, Bethesda, MD). Mouse monoclonal antibody against a clathrin heavy chain or N-cadherin were obtained from Transduction Laboratories. Mouse anti-FLAG and mouse anti-actin antibodies were obtained from Sigma.
Synaptosomal assay. The hippocampus or striatum from female rats (6 -7 weeks old) was homogenized in 0.32 M sucrose and 5 mM HEPES, pH 7.4, in a glass/Teflon homogenizer and centrifuged at 1000 ϫ g for 10 min. The supernatant was centrifuged at 12,000 ϫ g for 20 min, and the pellet was suspended in 0.32 M sucrose/HEPES. This suspension was re-centrifuged at 12,000 ϫ g for 30 min, and the pellet was resuspended in HBSS (in mM: 138 NaCl, 5.3 KCl, 1.3 CaCl 2 , 0.5 MgCl 2 , 0.4 MgSO 4 , 0.3 Na 2 HPO 4 , 0.4 KH 2 PO 4 , 4.2 NaHCO 3 , 10 HEPES, and 5.5 glucose, pH 7.4). Protein concentrations were determined using a BCA method (Pierce). This crude synaptosomal fraction was used immediately after preparation. Aliquots of synaptosomal suspensions were equilibrated to 37°C for 15 min. The incubation was terminated by centrifugation for 5 min at 4°C, and the synaptosomes were resuspended in ice-cold HBSS. Synaptosomes were then incubated with choline (or plus HC-3) for 15 min at 37°C. In the case of K ϩ depolarization, a half-volume of high K ϩ HBSS (5.3 mM NaCl and 138 mM KCl instead of the 138 mM NaCl and 5.3 mM KCl of normal HBSS) was added to give a final K ϩ concentration of 50 mM, and the synaptosomes were incubated for 15 min. In the case of K ϩ depolarization for the experiments on the choline uptake decline (see Fig. 6 ), a half-volume of high K ϩ HBSS was directly added to synaptosomal suspensions after the initial 15 min equilibration. The ligand preincubation or K ϩ depolarization was terminated by centrifugation for 5 min at 4°C, and the synaptosomes were resuspended in ice-cold HBSS. This wash was repeated, and the synaptosomes were washed a total of three times. For the choline oxidase pretreatment, synaptosomes were incubated with 10 U/ml choline oxidase (from Alcaligenes sp.; Sigma) in HBSS. The high-affinity [ 3 H]choline uptake assays were initiated through the addition of 100 l of synaptosomal suspensions (ϳ100 g) to 200 l of prewarmed 4 , 5.5 glucose, and 25 glycylglycine, pH 7.8. Both assays were terminated by washes with the corresponding buffer. The synaptosomes were collected onto 0.5% polyethylenimine-coated glass fiber filters (GF/B; Brandel) using a cell harvester. Assays were performed in triplicate, and specific uptake or binding was determined by subtraction of the amounts that were measured in the presence of 1 M nonlabeled HC-3. Kinetic constants were calculated using nonlinear least-square fits (Kaleidagraph; Synergy Software).
Primary cultures of the rat basal forebrain. Brain septal areas from day 17-18 rat embryos were dissected in Leibovitz's L-15 medium (Invitrogen). Tissue pieces were digested with 20 U/ml papain (Worthington), 1 mM L-cysteine, 0.5 mM EDTA, and 0.01% DNase I at 37°C for 15 min. The digestion was terminated by adding medium with 10% fetal bovine serum (FBS). The dissociation was completed mechanically by aspirating tissue pieces into a Pasteur pipette. Dissociated cells were plated at ϳ400,000 cells per well in 24-well tissue culture plates coated with 0.2% polyethylenimine (Sigma) and cultured in DMEM supplemented with 10% FBS at 37°C in 5% CO 2 for 2 weeks. . For transient CHT1 expression, 5 ϫ 10 5 cells were cultured in 24-well plates and transfected with 0.8 g of plasmid using Lipofectamine 2000 reagent. The cells were then used for [
3 H]HC-3 binding assay at 48 h after transfection. Cells were preincubated with HBSS at 37°C for 30 min and then with 20 M choline and/or 1 M HC-3 for additional 30 min. The preincubation was terminated by three washes with ice-cold HBSS, and the cells were kept on ice for 10 min for dissociation of the transporter-bound ligands. In the pH dependency experiments, the pH of HBSS was adjusted with 2-(Nmorpholino)ethanesulfonic acid/N-methyl-D-glucamine (NMDG), pH 5.5 and 6.5, or HEPES/NMDG, pH 7.5, 8.5, and 9.5. Binding assays were performed at 4°C for 1 h and terminated by three washes with ice-cold HBSS. In some experiments, uptake assays were performed for 5 min. Saturation kinetics were determined using [ 3 H]choline concentrations from 0.5 to 20 M with the specific activity diluted with unlabeled choline (50 Ci/mol). Uptake was terminated by three washes with ice-cold HBSS. Specific choline uptake was determined by subtracting the uptake in the presence of 1 M HC-3 from the total uptake. Assays were performed in triplicate and repeated in at least three separate experiments.
Cell-surface immunofluorescence microscopy. Cell lines stably expressing hCHT1 tagged with an N-terminal FLAG epitope (293-FLAG-h-CHT1) were grown on eight-well slide chambers (Nunc) or coverslips in 24-well plates. Cells were preincubated at 37°C for 30 min in HBSS, followed by incubation with ligands for 30 min. Cells were then fixed with 4% paraformaldehyde in PBS at 4°C for 20 min and blocked with 2% normal goat serum in PBS for 30 min. Fixed cells were incubated with mouse anti-FLAG monoclonal antibody (1:400; Sigma) for 1 h and then with Alexa Fluor 488-conjugated goat anti-mouse IgG antibody for 1 h in PBS. Immunostained cells were observed using an Olympus FV-1000 confocal system with a 40ϫ (NA 1.3) or 60ϫ (NA 1.35) oil-objective lens.
Cell-surface biotinylation and internalization assay. Cells grown on sixwell culture plates or 3.5 cm dishes were preincubated at 37°C for 30 min in HBSS. Cells were then treated with sulfo-NHS-SS-biotin (1.5-2.0 mg/ ml; Pierce) in HBSS at 4°C for 60 min. Unreacted biotin was washed and quenched by incubation with 20 mM glycine for 10 min. For the internalization assays, the cells were again incubated at 37°C in HBSS for various times after biotinylation. Internalization was terminated by washing of the cells with ice-cold HBSS. Residual biotins on the cell surface were cleaved by incubation with a cleavage buffer (50 mM glutathione, 70 mM NaCl, 80 mM NaOH, 1 mM EDTA, and 0.2% bovine serum albumin) twice at 4°C for 20 min. Free glutathione was then quenched using 5 mg/ml iodoacetamide twice for 5 min. Cells were solubilized with a lysis buffer (1% Triton X-100, 150 mM NaCl, 1 mM EDTA, and 20 mM HEPES, pH 7.4) at 4°C for 30 min. CHT1 proteins were almost completely soluble under this condition (data not shown). Cell lysates were centrifuged at 17,000 ϫ g for 10 min at 4°C. Biotinylated proteins were purified through incubation of the cell lysates with UltraLink Immobilized NeutrAvidin Protein Plus (Pierce) in RIPA buffer (1% Triton X-100, 0.5% deoxycholate, 0.1% SDS, 150 mM NaCl, 1 mM EDTA, and 20 mM HEPES, pH 7.4) overnight at 4°C. Beads were washed five times with 1 ml of RIPA buffer, and the proteins were eluted with SDS sample buffer (62.5 mM Tris-HCl, pH 6.8, 10% glycerol, 2% SDS, 0.1 M DTT, and 0.01% bromophenol blue). Precipitated proteins were analyzed by SDS-PAGE, followed by immunoblotting using anti-CHT1 antibody (1:2000) and an ECL detection kit (GE Healthcare). Protein levels were determined by measuring band density using NIH ImageJ software.
Small interfering RNAs. The small interfering RNAs (siRNAs) were purchased from Dharmacon. The following target sequences were selected: clathrin heavy chain, 5Ј-UCCAAUUCGAAGACCAAUU-3Ј; and AP-2 2 subunit, 5Ј-GUGGAUGCCUUUCGGGUCA-3Ј. The control siRNA was a nontargeting siRNA obtained from Dharmacon. Cells were cultured in six-well plates and transfected with 100 pmol of siRNA by using Lipofectamine RNAiMAX (Invitrogen) according to the instructions of the manufacturer. After 2 d, the cells were retransfected with siRNA, reseeded, and used for assays at 4 d after transfection (Motley et al., 2003) .
Statistical analysis. Data are represented as mean Ϯ SEM. Statistical significance was determined by one-way ANOVA (as indicated) or unpaired Student's t test (with Bonferroni's correction for multiple comparisons as indicated).
Results
Preincubation with ligands alters [ 3 H]choline uptake or [
3 H]hemicholinium-3 binding in rat brain synaptosomes or cultured CHT1-expressing cells Rat hippocampal synaptosomes were preincubated with choline and/or HC-3, a specific competitive inhibitor of the high-affinity choline transporter CHT1. HC-3 is a hydrophilic quaternary ammonium ligand and reversibly binds to CHT1 on the cell surface. After preincubation with the ligands, synaptosomes were rapidly washed to dissociate the ligands from the transporters, and the high-affinity [ 3 H]choline uptake was measured. We found that preincubation with 10 M choline for 15 min induced a significant decrease (20 -30%) in [ 3 H]choline uptake (Fig. 1 A; 78 Ϯ 1%, p Ͻ 0.01; n ϭ 4), which was blocked in the presence of 1 M HC-3, suggesting that the choline-induced decrease was mediated by CHT1 (Fig. 1 A) . Preincubation with HC-3 alone induced a slight increase (Fig. 1 A; 117 Ϯ 3%, n ϭ 4, p Ͻ 0.05). Preincubation of synaptosomes with the high K ϩ (50 mM) buffer for 15 min also increased [ 3 H]choline uptake by ϳ1.4-fold as described previously (Murrin and Kuhar, 1976) , presumably because of depolarization-triggered vesicular trafficking of intracellular CHT1 to the plasma membrane (Fig. 1 A) . (Fig. 1 A, right; HC-3, 112 Ϯ 3%, p Ͻ 0.05; K ϩ , 124 Ϯ 5%, p Ͻ 0.05; n ϭ 4). We also examined [ 3 H]HC-3 binding in primary cultures from the rat basal forebrain that endogenously express CHT1. The binding progressively increased during culturing until 14 d in vitro (DIV) as long as we examined (data not shown). Similar to results from synaptosomes, preincubation of cultures at DIV12-14 with 10 M choline induced a significant decrease (ϳ20%) in [
3 H]HC-3 binding, but preincubation with HC-3 increased it by ϳ1.5-fold (Fig. 1 B; choline, 80 Ϯ 4%, p Ͻ 0.05; HC-3, 156 Ϯ 11%, p Ͻ 0.05; n ϭ 3). These results indicate that preincubation with choline induces a significant decrease in [ 3 H]choline uptake or [ 3 H]HC-3 binding in cholinergic nerve terminals, possibly by decreasing the expression level of CHT1 at the plasma membrane, whereas HC-3 preincubation induces an increase. We postulate that these ligands promote CHT1 redistribution by regulating its internalization rate because it is unlikely that these hydrophilic ligands directly affect intracellular CHT1 trafficking.
The effects of ligand preincubation on [ Fig. 1C ; HC-3, 153 Ϯ 5%, p Ͻ 0.01; n ϭ 3). These effects of ligand preincubation were similar to the above results in synaptosomes or primary cultures and were similarly observed in other hCHT1-transfected cell lines, including COS-7, HEK293, and HeLa cells (data not shown), implying that ligand-induced changes in cellsurface expression level is a constant feature of the high-affinity choline transporter expressed in a variety of cultured cells.
Preincubation with ligands alters the cell-surface expression level of CHT1 in HEK293 cells HEK293 cells were selected as a model expression system for characterizing the ligand-induced changes in cell-surface CHT1. HEK293 cell lines stably expressing human CHT1 (293-hCHT1) were generated, and CHT1-specific [
3 H]HC-3 binding was measured after preincubation with ligands. Preincubation with a saturating concentration of choline (20 M) induced a ϳ70% decrease in [ 3 H]HC-3 binding, whereas preincubation with 1 M HC-3 resulted in a twofold to fourfold increase (Fig. 2 A; choline, 31 Ϯ 3%, p Ͻ 0.001; HC-3, 256 Ϯ 37%, p Ͻ 0.01; n ϭ 4). Saturation kinetic analysis of [
3 H]HC-3 binding after ligand preincubation showed that these changes was mainly attributable to changes in B max (Fig. 2 B; control, 5.0 Ϯ 0.4 pmol/mg protein; (Fig. 2C,D) . Incubation with 20 M choline or 1 M HC-3 induced rapid changes in the binding within minutes ( Fig. 2C ; t 1/2 ϭ 1.0 Ϯ 0.1 min for choline, 3.7 Ϯ 0.6 min for HC-3; n ϭ 3), with an apparent half-maximal effective concentration (EC 50 ) of 2.1 Ϯ 0.5 M or 16 Ϯ 1 nM (n ϭ 3), respectively (Fig. 2 D) . The potency of the ligands was similar to the ligandbinding affinity of CHT1 (K m for choline, 1.6 M; K d for HC-3, 24 nM; Fig. 2 B, H ) . These ligand-induced changes were not observed when ligands were preincubated under Na ϩ -free conditions, indicating that the ligand effects are Na ϩ dependent (Fig. 2 E) . A significant increase in the basal [
3 H]HC-3 binding induced by preincubation with Na ϩ -free buffer suggests that the constitutive internalization of CHT1 is Na ϩ dependent (236 Ϯ 9% relative to control, p Ͻ 0.01; n ϭ 3). In summary, these results suggest that the above-mentioned ligand effects were mediated by their direct interactions with CHT1.
The effect of ligand preincubation on CHT1-mediated choline uptake was consistent with the above results. Preincubation with 20 M choline resulted in a 40 -60% decrease in CHT1-mediated [ 3 H]choline uptake, whereas preincubation with 1 M HC-3 induced a 1.5-fold to 2-fold increase ( Fig. 2F ; choline, 54 Ϯ 6%, p Ͻ 0.05; HC-3, 159 Ϯ 6%, p Ͻ 0.01; n ϭ 3). The time courses of these changes in [ (Fig. 2H) .
Cell-surface biotinylation assays using a membrane-impermeable biotin reagent were performed to assess CHT1 cell-surface expression. Preincubation with 10 Mcholine significantly decreased the amount of cell-surface biotinylated CHT1, whereas preincubation with 1 MHC-3 plus choline or HC-3 alone significantly increased it without affecting total CHT1 cellular expression (Fig. 3A) . Quantification of the immunoreactive bands showed that these changes in the amounts of cell-surface CHT1 were similar to those in specific [ (Fig. 3B) . To visualize the cellsurface distribution of CHT1, we generated HEK293 cell lines that stably expressed hCHT1 tagged with a FLAG epitope at the extracellular-facing N-terminal end (FLAG-hCHT1). Ligand preincubation induced changes in [ 3 H]HC-3 binding in 293-FLAGhCHT1 cells as in 293-hCHT1 cells (data not shown). When 293-FLAG-hCHT1 cells were permeabilized and stained with a FLAG antibody, predominant intracellular localization of CHT1 protein was observed (Fig. 3C, left) , similar to the distribution of CHT1 expressed in other cells Ribeiro et al., 2003) . However, only signals derived from the cell surface were observed when the cells were not permeabilized before staining (Fig.  3C, right) . As a result, we preincubated the cells with ligands and selectively labeled the CHT1 on the cell surface. Immunofluorescent analysis showed that preincubation with 20 M choline significantly decreased the fluorescence signal, whereas preincubation with 1 M HC-3 significantly increased it (Fig. 3D) . 
The CHT1 internalization rate is regulated by extracellular ligands
The above results raise the possibility that ligand preincubation may affect CHT1 internalization rate. To explore this possibility, the internalization rate of the cell-surface CHT1 protein was measured in the presence of choline or HC-3 in 293-hCHT1 cells. Cell-surface proteins were first labeled with a thiol-cleavable biotin reagent at 4°C, and the cells were then returned to 37°C to allow for the endocytosis to proceed. After the indicated time periods, biotin-labeled proteins remaining on the cell surface were selectively cleaved by the membrane-impermeable reducing agent glutathione. Biotinylated proteins that were protected from the cleavage, which should represent intracellular proteins, were evaluated by immunoblot analysis. As shown in Figure 3E , biotinylated CHT1 was rapidly internalized within 30 min. The internalization was accelerated in the presence of 20 M choline but greatly reduced in the presence of 1 M HC-3. Here, the extent of ligand-induced CHT1 internalization rate changes may be underestimated because biotin-labeled CHT1 has impaired choline uptake or HC-3 binding activity compared with nonlabeled CHT1 (20-40% of control), suggesting diminished ligand-binding activity of an excessively biotinylated transporter. These results show that extracellular choline increases the CHT1 internalization rate, whereas HC-3 significantly decreases it, indicating that ligand binding directly affects the internalization rate and thus alters CHT1 cell-surface expression in HEK293 cells.
Choline-induced CHT1 internalization is mediated by a clathrin-independent, dynamin-dependent endocytosis pathway CHT1 is constitutively internalized in the clathrin-mediated endocytosis pathway in cultured cells (Ribeiro et al., 2003 (Ribeiro et al., , 2005 . To examine its role in cholineinduced CHT1 internalization, we used Figure 3 . Ligand preincubation alters the CHT1 cell-surface expression level by regulating its internalization rate. A, Cell-surface biotinylation assay in 293-hCHT1 cells. After preincubation of cells with 10 M choline (Ch) and/or 1 M HC-3, cell-surface proteins were biotinylated by incubating cells with a membrane-impermeable sulfo-NHS-SS-biotin at 4°C. Cell-surface biotinylated proteins ("Biotinylated") and total proteins ("Total lysate") were immunoblotted with an antibody against CHT1 or actin. The cell-surface biotinylation specificity was confirmed by depleted actin signals in the biotinylated fractions. The densitometric quantification of the immunoreactive bands is shown on the right. B, Dose-dependent effects of ligand preincubation on the amount of cell-surface biotinylated CHT1. C, Immunofluorescence analysis of 293-FLAG-hCHT1 cells. The cells were permeabilized or not using 0.2% Triton X-100 and subjected to FLAG antibody staining. Note that heterologous expression of CHT1 in mammalian cell lines generally results in predominant intracellular localization and low expression in the plasma membrane (left). Scale bar, 20 m. D, Cell-surface staining of 293-FLAG-hCHT1 cells after preincubationwith20Mcholineor1MHC-3.Scalebar,20m.E,Internalizationofthecell-surfacebiotinylatedCHT1.Aftercell-surface protein biotinylation, the cells were allowed to complete endocytosis through incubation at 37°C with 20 M choline or 1 M HC-3. The biotinylated proteins that were protected from glutathione-mediated cleavage were evaluated by immunoblot analysis using a CHT1 4 antibody. PM, Plasma membrane fraction that was prepared from cells kept at 4°C without the cleavage. The densitometric analysis for the time courses of CHT1 internalization in the presence of choline or HC-3 is shown in the bottom. The data are normalized to levels observed in the plasma membrane fraction.
siRNAs to knock down the expression of the 2 subunit of the clathrin adaptor protein AP-2 complex, or clathrin heavy chain, which is essential for clathrin-mediated endocytosis. Transfection of 293-hCHT1 cells with siRNA against each target significantly depleted each expression level as assessed by immunoblot analysis (Fig. 4 A) . In AP-2-or clathrin-depleted cells, the basal cell-surface expression level of CHT1 was significantly increased relative to each total expression level, suggesting that the constitutive internalization of CHT1 is mediated at least in part by the clathrin-mediated endocytosis pathway as reported previously (Ribeiro et al., 2003 (Ribeiro et al., , 2005 (Fig. 4 A) . In those cells, however, preincubation with 20 M choline or 1 M HC-3 changed cellsurface CHT1 expression in a similar manner to control cells as assessed by cell-surface biotinylation assays (Fig. 4 B) . These changes were specific to surface CHT1 because expression levels of total CHT1 were unaffected (Fig. 4 B) . Similar cholineregulated changes were confirmed using a [
3 H]HC-3 binding assay (Fig. 4C) . Furthermore, overexpression of the C terminus of AP180, which is known to inhibit the clathrin-mediated endocytosis in a dominant-negative manner (Ford et al., 2001) , increased the basal cell-surface expression level of CHT1 by approximately threefold but had no significant effect on cholineregulated cell-surface CHT1 as assessed by a [
3 H]HC-3 binding assay (Fig. 4 D) .
Some clathrin-independent endocytosis pathways are dependent on dynamin (Doherty and McMahon, 2009 ). To examine whether choline-induced CHT1 internalization is dynamin dependent, a dominant-negative mutant (K44A) of dynamin 2 was coexpressed with hCHT1 in HEK293 cells to disrupt dynamin-mediated endocytosis. Expression of the dynamin mutant increased the basal cell-surface CHT1 expression level, suggesting that the constitutive internalization of CHT1 is dynamin dependent, as reported previously (Ribeiro et al., 2005) (Fig. 4 E, F, top) . We found that the cholineinduced decrease in [
3 H]HC-3 binding was attenuated significantly by dynamin mutant expression (Fig. 4 E; choline, 96 Ϯ 5% relative to control in the mutant-expressing cells; p Ͼ 0.5; n ϭ 3) but not by wild-type dynamin (Fig. 4 E; choline, 61 Ϯ 1% relative to control; p Ͻ 0.001; n ϭ 3). Cell-surface biotinylation assays also showed that choline-induced changes in cell-surface CHT1 were markedly inhibited in cells expressing the dynamin mutant (Fig. 4 F, bottom) .
Together, extracellular choline induces CHT1 internalization via a clathrin-independent but dynamin-dependent endocytosis pathway in HEK293 cells.
Extracellular pH regulates CHT1 cell-surface expression level in HEK293 cells
CHT1 has been reported to show pH-dependent choline uptake or HC-3 binding activity when expressed in Xenopus oocytes (Iwamoto et al., 2006) . The mechanism of pH-dependent regulation is not clear, but it may be attributable to the direct interaction of proton (or hydroxide ion) with some sites that are critical for CHT1 ligand-binding activity. Accordingly, we observed extracellular pH-dependent [ 3 H]choline uptake or [ 3 H]HC-3 binding activity of CHT1 in HEK293-hCHT1 cells (Fig. 5 A, B) . Importantly, we found that changes in extracellular pH induced altered CHT1 cell-surface expression as assessed by a [
3 H]HC-3 binding assay. Preincubation of cells with various pH buffers significantly changed the [ 3 H]HC-3 binding activity at physiological pH of 7.4, in which preincubation with a higher pH buffer resulted in higher binding activity (Fig. 5C ). Extracellular pHinduced changes in [ 3 H]choline uptake were similarly observed (Fig. 5D) . Here, the extent of changes in [ 3 H]choline uptake was somewhat different from those in [ 3 H]HC-3 binding, which was true for the ligand-induced changes (Fig. 2) . This may be attributable to a difference in assay conditions (30°C vs 4°C): constitutive internalization/recycling proceeded during the choline uptake assays, which may have diminished the cell-surface expression level changes. Alternatively, there may be at least two pools of CHT1 on cell surface that are capable of ligand binding, Figure 4 . Choline-induced CHT1 internalization is mediated by a clathrin-independent, dynamin-dependent endocytosis pathway. A, Immunoblot analysis of total cell lysates from 293-hCHT1 cells transfected with siRNAs directed against each target. Equal amounts of protein were subjected to SDS-PAGE, and the blots were probed with the indicated antibodies. In clathrin-depleted cells, the total CHT1 expression level was significantly decreased compared with that in control cells, presumably because clathrin is required for intracellular vesicular trafficking and stable expression of CHT1. Clathrin hc, Clathrin heavy chain. B, Cell-surface biotinylation assay in cells transfected with siRNAs. After preincubation of cells with 20 M choline (Ch) or 1 M HC-3, the cell-surface proteins were biotinylated at 4°C. The biotinylated proteins were immunoblotted using a CHT1 antibody. KD, Knockdown. C, [ 3 H]HC-3 binding after ligand preincubation in 293-hCHT1 cells transfected with siRNAs against the proteins related to the clathrin-mediated endocytosis. but only one pool is functional for substrate transport. The cellsurface biotinylation assay also showed that the CHT1 cellsurface expression level depends on external pH, a finding that is consistent with the [ 3 H]HC-3 binding assay results (Fig. 5E ). This pH dependency was not observed in other surface proteins, such as N-cadherin (Fig. 5E, bottom) . Compared with the internalization rate at pH 7.5, that at pH 5.5 was accelerated and that at pH 9.5 was reduced, indicating that extracellular pH alters the CHT1 cell-surface expression level by regulating the CHT1 internalization rate in HEK293 cells (Fig. 5F ).
Characterization of substrate-regulated high-affinity choline uptake in rat brain synaptosomes: contribution of endogenous choline As initially described, the decrease in [ 3 H]choline uptake or [
3 H]HC-3 binding was observed after 15 min choline preincubation of hippocampal synaptosomes (Fig. 1 A) . Saturation kinetic analysis of [ 3 H]choline uptake with or without choline preincubation showed that the decrease induced by choline preincubation was mainly attributable to a decrease in V max (control, 3.0 Ϯ 0.1 pmol/min/mg protein; choline, 2.4 Ϯ 0.03 pmol/min/mg protein; n ϭ 3) but not an alteration of K m (control, 0.42 Ϯ 0.04 M; choline, 0.47 Ϯ 0.04 M; n ϭ 3) (Fig. 6 A) . However, this decrease in [ 3 H]choline uptake was not evident when synaptosomes were preincubated with choline for 30 min. We therefore examined the time course of choline preincubation on [
3 H]choline uptake. We found that the [ 3 H] choline uptake of synaptosomes gradually decreased during preincubation at 37°C at the basal state, and addition of 10 M choline induced a rapid decrease, a finding that explains the above discrepancy (Fig. 6 B) . Because it is possible that choline is released extracellularly from synaptosomes and stimulates CHT1 internalization during preincubation, synaptosomes were treated with choline oxidase to disrupt the endogenous choline before [ 3 H]choline uptake measurement. We found that choline oxidase treatment during preincubation blocked the decrease in the basal [
3 H]choline uptake (Fig. 6 B) . These results suggest that endogenously released choline during the preincubation step sig- The above studies focused on choline uptake at the basal state. Once the choline uptake was upregulated by K ϩ depolarization as initially described, it declined to the control level within 30 min when the synaptosomes were reincubated with normal buffer at 37°C (Fig. 6C) . We next focused on the decline after K ϩ depolarization and found that incubation with 10 M choline accelerated the return to the control uptake level (Fig. 6C) , during which the time course curve shifted to the left compared with the control (t 1/2 : control, 4.9 Ϯ 0.6 min; choline, 2.7 Ϯ 0.2 min; p Ͻ 0.05; n ϭ 3). In contrast, incubation with 1 M HC-3 blocked the decline in choline uptake (Fig. 6C) . When synaptosomes were examined at 5 min after K ϩ depolarization, the extracellular choline induced a significant decrease in [ 3 H]HC-3 binding compared with the control, whereas incubation with 1 M HC-3 blocked the return to the control level (Fig. 6 D) . Together, these results indicate that extracellular choline accelerates the decline in choline uptake, possibly by enhancing the CHT1 internalization rate, whereas HC-3 blocks the decline by slowing its internalization rate, at the basal or post-activated state in brain synaptosomes.
Discussion
Here we demonstrated that an extracellular substrate decreases the CHT1 cell-surface expression level by inducing its internalization in various experimental systems. In rat brain synaptosomes, primary cultures, and mammalian cell lines expressing CHT1, extracellular choline induces a rapid decrease in the CHT1 cell-surface expression level by accelerating its internalization. In contrast, the specific inhibitor HC-3 decreases the constitutive internalization rate and thereby increases the CHT1 cell-surface expression level.
The endocytosis of many receptors, such as G-proteincoupled receptors or receptor tyrosine kinases, is well known to be stimulated by ligand-induced activation (Sorkin and von Zastrow, 2009 ). Likewise, the cell-surface expression level of transporters, such as neurotransmitter transporters, can also be regulated by endocytic trafficking in the presence of extracellular substrate (Melikian, 2004) . However, unlike receptors that generally internalize after agonist binding, transporter responses to the extracellular substrate are unpredictable. For example, after preincubation with a substrate, the dopamine transporter DAT is downregulated (Saunders et al., 2000; Chi and Reith, 2003) , whereas the glutamate transporter GLAST or GABA transporter GAT1 is upregulated (Bernstein and Quick, 1999; Duan et al., 1999) . In the case of GAT1, tyrosine phosphorylation is associated with substrate-regulated endocytic trafficking (Whitworth and Quick, 2001) . It is not known whether posttranslational modifications, such as phosphorylation, are involved in substrateinduced CHT1 internalization.
The molecular mechanism of choline-induced CHT1 internalization is not yet clear. It seems unlikely that it is mediated by mere intracellular choline accumulation because extracellular choline does not induce internalization in the absence of Na ϩ or in the presence of HC-3, a situation in which a significant amount of choline is still taken up by endogenous Na ϩ -independent, HC-3-insensitive transporters into the cells. Rather, considering the opposite effect of the competitive inhibitor HC-3, it is feasible to postulate the regulation of CHT1 internalization by transporter conformation. One possibility is that a choline-bound or inward-facing CHT1 conformation may facilitate its targeting to the cellular endocytic machinery by recruiting some endocytic proteins; HC-3 binding may stabilize an outward-facing CHT1 conformation, precluding its endocytic targeting. When expressed in Xenopus oocytes, CHT1 exhibits a leak current in the absence of substrate (Iwamoto et al., 2006) , which may explain that constitutive CHT1 internalization is dependent on spontaneous conformational changes of CHT1. If conformation-based regulation is the case, pH-regulated internalization of CHT1 in HEK293 cells may be interpreted by the idea that proton-bound CHT1, which shows low choline uptake or HC-3 binding activity, may exhibit an inward-facing conformation, which facilitates its targeting of endocytic machinery. Although our results show that choline-induced internalization is mainly mediated by a clathrinindependent, dynamin-dependent endocytosis pathway in HEK293 cells, it is unknown how the conformational change of CHT1 is coupled to endocytosis, and we still cannot exclude the possibility that clathrin-mediated endocytosis has a role in choline-induced CHT1 internalization.
CHT1 expression at the plasma membrane is essential for acetylcholine synthesis, and our results suggest that extracellular choline concentration at the cholinergic terminals is critical. Although extracellular choline concentrations at the synapses are not known, the choline concentration in the CSF is estimated to be 0.7-2.1 M in humans (Flentge et al., 1984; Tohgi et al., 1996) , a near-saturating concentration for CHT1 (K m of ϳ0.5 M in rat brain synaptosomes), suggesting that endogenous extracellular choline concentration is sufficient to enable the continuous CHT1 internalization. The recent findings that most CHT1 are localized at synaptic vesicles Ribeiro et al., 2003; Nakata et al., 2004 ) may be at least partly explained by this sustained substrate-induced internalization. As revealed by HC-3-mediated increase in cell-surface CHT1, it also seems that the constitutive CHT1 internalization is coupled with endogenous transporter activity even without substrate, which may also contribute to the predominant intracellular CHT1 localization. Interestingly, Rylett et al. (1993) reported an HC-3-induced increase in the high-affinity choline uptake in rat synaptosomes, a finding that is partly similar to our observations. Considering the concentration of endogenous extracellular choline, it is also suggested that fluctuation of the choline concentration affects CHT1 expression level at the plasma membrane, especially under depolarized conditions in which extracellular choline concentration would be higher as a result of liberation after the hydrolysis of synaptically released acetylcholine by acetylcholinesterase.
